利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

4 条记录 (耗时 0.035 秒)

    Dimeric compounds and their use as anti-viral agents
    3.
    发明授权
    Dimeric compounds and their use as anti-viral agents 失效
    二聚体化合物及其作为抗病毒剂的用途

    公开(公告)号：US07214707B2

    公开(公告)日：2007-05-08

    申请号：US10494242

    申请日：2002-11-08

    申请人： Derek A. Demaine ,  Haydn T. Jones ,  Simon J. F. MacDonald ,  Andrew McM Mason ,  Stephen E. Shanahan

    发明人： Derek A. Demaine ,  Haydn T. Jones ,  Simon J. F. MacDonald ,  Andrew McM Mason ,  Stephen E. Shanahan

    IPC分类号： A61K31/35

    CPC分类号： A61K45/06 ,  A61K31/13 ,  A61K31/351 ,  A61K31/7056 ,  A61K47/54 ,  A61K47/55 ,  C07D309/28 ,  A61K2300/00

    摘要： The invention relates to compounds of general formula (I), in which: R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; n and q are either the same or different and selected from 0, 1 or 2; and X is an optionally substituted phenyl, optionally substituted naphthyl or optionally substituted phenyl-Y-optionally substituted phenyl in which Y is selected from a covalent bond, CH2, CH2CH2, O or SO2, or a pharmaceutically acceptable derivative thereof, with the proviso that when X is phenyl or naphthyl, n and q are both 2 and when X is phenyl-Y-phenyl in which Y is a covalent bond, then n and q are not both 0, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection

    摘要翻译： 本发明涉及通式（I）的化合物，其中：R是氨基或胍基; R 2是乙酰基或三氟乙酰基; n和q相同或不同，选自0,1或2; 并且X是任选取代的苯基，任选取代的萘基或任选取代的苯基-Y-任选取代的苯基，其中Y选自共价键，CH 2，CH 2， CH 2，O或SO 2，或其药学上可接受的衍生物，条件是当X是苯基或萘基时，n和q都是2，当X是 苯基-Y-苯基，其中Y是共价键，则n和q不同时为0，其制备方法，含有它们的药物制剂或其用于预防或治疗病毒感染

    Dimeric compounds and their use as anti-viral agents
    4.
    发明授权
    Dimeric compounds and their use as anti-viral agents 有权
    二聚体化合物及其作为抗病毒剂的用途

    公开(公告)号：US07504434B2

    公开(公告)日：2009-03-17

    申请号：US11695268

    申请日：2007-04-02

    申请人： Derek A. Demaine ,  Haydn T. Jones ,  Simon J. F. MacDonald ,  Andrew McM Mason ,  Stephen E. Shanahan

    发明人： Derek A. Demaine ,  Haydn T. Jones ,  Simon J. F. MacDonald ,  Andrew McM Mason ,  Stephen E. Shanahan

    IPC分类号： A61K31/351

    CPC分类号： A61K45/06 ,  A61K31/13 ,  A61K31/351 ,  A61K31/7056 ,  A61K47/54 ,  A61K47/55 ,  C07D309/28 ,  A61K2300/00

    摘要： The invention relates to compounds of general formula (I), in which: R is an amino or guanidino group; R2 is acetyl or trifluoroacetyl; n and q are either the same or different and selected from 0, 1 or 2; and X is an optionally substituted phenyl, optionally substituted naphthyl or optionally substituted phenyl-Y-optionally substituted phenyl in which Y is selected from a covalent bond, CH2, CH2CH2, O or SO2, or a pharmaceutically acceptable derivative thereof, with the proviso that when X is phenyl or naphthyl, n and q are both 2 and when X is phenyl-Y-phenyl in which Y is a covalent bond, then n and q are not both 0, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection.

    摘要翻译： 本发明涉及通式（I）的化合物，其中：R是氨基或胍基; R2是乙酰基或三氟乙酰基; n和q相同或不同，选自0,1或2; CH 2，CH 2 CH 2，O或SO 2，或其药学上可接受的衍生物，其中Y是任选取代的苯基，任选取代的萘基或任选取代的苯基-Y-任选取代的苯基，其中Y选自共价键， 当X是苯基或萘基时，n和q都是2，当X是其中Y是共价键的苯基-Y-苯基时，n和q都不是0，它们的制备方法，含有它们的药物制剂或它们 用于预防或治疗病毒感染。